Engensis
Sponsors
Helixmith Co., Ltd.
Conditions
Amyotrophic Lateral SclerosisDiabetic Neuropathy, PainfulDiabetic Peripheral Neuropathy
Phase 2
Safety of Engensis in Participants With Amyotrophic Lateral Sclerosis
CompletedNCT04632225
Start: 2021-03-09End: 2024-07-15Updated: 2025-10-06
A 6-Month Extension Study to Assess the Long-Term Safety of Engensis in Amyotrophic Lateral Sclerosis
CompletedNCT05176093
Start: 2021-11-14End: 2024-08-23Updated: 2025-10-06
Phase 3
Study to Assess Safety and Efficacy of Engensis in Painful Diabetic Peripheral Neuropathy
CompletedNCT04469270
Start: 2020-11-20End: 2024-07-31Updated: 2025-10-09
A 6-Month Extension Study of VMDN-003-2 to Assess Engensis in Participants With Painful Diabetic Peripheral Neuropathy
CompletedNCT04873232
Start: 2021-05-17End: 2024-07-23Updated: 2025-10-09